Document Detail


Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran.
MedLine Citation:
PMID:  20413287     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Research evidence indicates that prisoners in Iran are at risk of drug-related harm, including acquisition of blood-borne infections. In response, several prevention interventions including methadone maintenance treatment (MMT) have been introduced into prisons in Iran.
METHODS: This report reviews and presents some important information extracted from published articles, and available documents on HIV sentinel surveillance and provision of MMT inside correctional settings in Iran.
RESULTS: Biological surveillance data in 2005 showed that on average about 3% of prisoners in the country tested positive for HIV infection. MTT that constitutes a main component of the Prison Organisation's HIV prevention package is becoming increasingly accessible to opioid-dependent prisoners. Between 2002 and 2008, the number of opioid-dependent prisoners receiving MMT increased steadily from 100 to more than 25000.
CONCLUSION: Experiences in Iran suggest that access to MMT would be helpful for reducing illicit drug injection in a prison setting and can be considered as a major intervention for preventing the transmission of blood-borne infections among prisoners.
Authors:
Marziyeh Farnia; Bahman Ebrahimi; Ali Shams; Saman Zamani
Related Documents :
23087327 - High risk medicolegal autopsies: is a full postmortem examination necessary?
23237167 - Interactions between hiv/aids and the environment: toward a syndemic framework.
22994247 - Meta-analysis of single-session behavioral interventions to prevent sexually transmitte...
22947277 - An hiv infection model based on a vectored immunoprophylaxis experiment.
23517547 - Risk factors of tuberculosis infection among hiv/aids patients in burkina faso.
8522377 - Levels of the circulating cell adhesion molecule e-selectin and disease progression in ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review     Date:  2010-04-21
Journal Detail:
Title:  The International journal on drug policy     Volume:  21     ISSN:  1873-4758     ISO Abbreviation:  Int. J. Drug Policy     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-08-23     Completed Date:  2011-02-01     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9014759     Medline TA:  Int J Drug Policy     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  422-4     Citation Subset:  IM    
Copyright Information:
Copyright 2010 Elsevier B.V. All rights reserved.
Affiliation:
The Iran Prison Organisation, Tehran, Iran.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Alcoholism / drug therapy,  rehabilitation
Analgesics, Opioid / administration & dosage,  therapeutic use*
HIV Infections / epidemiology,  prevention & control,  transmission
Health Services Accessibility
Humans
Iran / epidemiology
Methadone / administration & dosage,  therapeutic use*
Opiate Substitution Treatment*
Opioid-Related Disorders / drug therapy*,  rehabilitation*
Prisoners*
Prisons
Risk-Taking
Substance Abuse, Intravenous / drug therapy,  rehabilitation
Chemical
Reg. No./Substance:
0/Analgesics, Opioid; 76-99-3/Methadone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  FRAP and kinetic modeling in the analysis of nuclear protein dynamics: what do we really know?
Next Document:  Guidelines for better harm reduction: Evaluating implementation of best practice recommendations for...